Latest News about RCUS
Recent news which mentions RCUS
Gilead-Arcus Partnered Domvanalimab Combo Study Show Improved Progression-Free Survival In Lung Cancer Patients
December 20, 2022
From Benzinga
Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures
November 28, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
From Benzinga
ON Semiconductor, Global Payments And Other Big Losers From Monday
November 01, 2022
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
From Benzinga
Citi reduces Arcus Biosciences (RCUS) PT to $40. RCUS is currently trading at $25.45.
August 18, 2022
Tickers
RCUS
From Best Stocks
From Benzinga
99 Biggest Movers From Yesterday
May 12, 2022
From Benzinga
From Benzinga
52 Stocks Moving In Wednesday's Mid-Day Session
May 11, 2022
From Benzinga
From Benzinga
From InvestorPlace
34 Stocks Moving in Wednesday's Pre-Market Session
May 11, 2022
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For May 9, 2022
May 09, 2022
From Benzinga
From Benzinga
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
April 11, 2022
From Benzinga
51 Biggest Movers From Yesterday
April 06, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 05, 2022
From Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
April 05, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 05, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.